Pharma companies have different approaches on prerequisites for software to be used in GCP environment. Would be very interested on exchange and discussion about this and what would be required for this Sankey mod to be used in your company and use cases.
To enable the use of this mod in Pharma context a documentation and testing is required to allow usage in ICH E6 GCP regulated use cases https://www.ema.europa.eu/en/ich-e6-r2-good-clinical-practice.
Pharma companies have different approaches on prerequisites for software to be used in GCP environment. Would be very interested on exchange and discussion about this and what would be required for this Sankey mod to be used in your company and use cases.